| __timestamp | Amneal Pharmaceuticals, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 1643000000 |
| Thursday, January 1, 2015 | 109679000 | 1532000000 |
| Friday, January 1, 2016 | 118757000 | 1364000000 |
| Sunday, January 1, 2017 | 109046000 | 1334000000 |
| Monday, January 1, 2018 | 230435000 | 1484000000 |
| Tuesday, January 1, 2019 | 289598000 | 1638000000 |
| Wednesday, January 1, 2020 | 326727000 | 1726000000 |
| Friday, January 1, 2021 | 365504000 | 2001000000 |
| Saturday, January 1, 2022 | 399700000 | 2009000000 |
| Sunday, January 1, 2023 | 429675000 | 2151000000 |
Unveiling the hidden dimensions of data
In the world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This chart compares the SG&A expenses of Zoetis Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Zoetis Inc. consistently outspent Amneal Pharmaceuticals, with expenses peaking at approximately $2.15 billion in 2023, a 30% increase from 2014. In contrast, Amneal Pharmaceuticals saw a more dramatic rise, with expenses growing by over 400% from $84 million in 2014 to $430 million in 2023. This stark difference highlights Zoetis's larger scale and market presence, while Amneal's rapid growth reflects its aggressive expansion strategy. Understanding these trends provides valuable insights into each company's operational strategies and market positioning.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and argenx SE
Who Optimizes SG&A Costs Better? Zoetis Inc. or Opthea Limited
Zoetis Inc. vs Amneal Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Breaking Down SG&A Expenses: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Perrigo Company plc Trends and Insights
Selling, General, and Administrative Costs: Zoetis Inc. vs Wave Life Sciences Ltd.
Takeda Pharmaceutical Company Limited and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Intra-Cellular Therapies, Inc. vs Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc. Trends and Insights
Amneal Pharmaceuticals, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared